Showing results (231-240 of 465) with videos related to

Sort By:
Pageof 47
Rheumatology (Oxford, England)|May 18, 2016
The relationship between three-dimensional knee MRI bone shape and total knee replacement-a case control study: data from the Osteoarthritis InitiativeAndrew J Barr, Bright Dube, Elizabeth M A Hensor, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Are pain severity and current pharmacotherapies associated with quality of life, work productivity, and healthcare utilisation for people with osteoarthritis in five large European countries?Philip G Conaghan, Michael J Doane, Dena Hirschfield Jaffe, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
Disease modification in osteoarthritis; pathways to drug approvalJeffrey N Katz, Tuhina Neogi, Leigh F Callahan, et al.
The Journal of Orthopaedic and Sports Physical Therapy|June 20, 2019
Toward the Development of Data-Driven Diagnostic Subgroups for People With Patellofemoral Pain Using Modifiable Clinical, Biomechanical, and Imaging FeaturesBenjamin T Drew, Philip G Conaghan, Toby O Smith, et al.
Arthritis and Rheumatism|January 11, 2005
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trialMark A Quinn, Philip G Conaghan, Philip J O'Connor, et al.
Bone & Joint Open|April 13, 2023
Mid- to late-term follow-up of primary hip and knee arthroplasty: the UK SAFE evidence-based recommendationsSarah R Kingsbury, Lindsay K K Smith, Rafael Pinedo-Villanueva, et al.
Advances in Rheumatology (London, England)|April 22, 2024
Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritisThomas J Schnitzer, Philip G Conaghan, Francis Berenbaum, et al.
BMJ Open|March 10, 2022
UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national datasets tell us about mid-late term revision risk after knee replacement?Lindsay K Smith, Cesar Garriga, Sarah R Kingsbury, et al.
Annals of Internal Medicine|August 4, 2020
Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialMatthias Schieker, Philip G Conaghan, Linda Mindeholm, et al.
Lancet (London, England)|March 29, 2026
Efficacy and safety of LEVI-04 in patients with osteoarthritis of the knee: a randomised, double-blind, placebo-controlled, phase 2 trialPhilip G Conaghan, Nathaniel Katz, Asger R Bihlet, et al.
Pageof 47